Global Naloxone Hydrochloride for Injection Market Growth 2022-2028
The global market for Naloxone Hydrochloride for Injection is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Naloxone Hydrochloride for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Naloxone Hydrochloride for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Naloxone Hydrochloride for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Naloxone Hydrochloride for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Naloxone Hydrochloride for Injection players cover AuroMedics Pharma, Narcan, Somerset Therapeutics, Flagship Biotech International and Livealth BioPharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Naloxone Hydrochloride for Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Naloxone Hydrochloride for Injection market, with both quantitative and qualitative data, to help readers understand how the Naloxone Hydrochloride for Injection market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Naloxone Hydrochloride for Injection market and forecasts the market size by Specification (1ml/Unit, 2ml/Unit and 10ml/Unit), by Application (Hospital Pharmacy, Retail Pharmacy and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by specification
1ml/Unit
2ml/Unit
10ml/Unit
Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
AuroMedics Pharma
Narcan
Somerset Therapeutics
Flagship Biotech International
Livealth BioPharma
Shanxi PUDE Pharmaceutical
Chengdu Easton Bio Pharmaceuticals
HeBei Aoxing Group Pharmaceutical
Hunan Kangzhe Pharmaceutical
Beijing Sihuan Pharmaceutical
Hainan Bikai Pharmaceutical
Chengdu Tiantai Mountain Pharmaceutical
Shandong Xinhua Pharmaceutical
Xi'an Disai Biopharmaceutical
Chapter Introduction
Chapter 1: Scope of Naloxone Hydrochloride for Injection, Research Methodology, etc.
Chapter 2: Executive Summary, global Naloxone Hydrochloride for Injection market size (sales and revenue) and CAGR, Naloxone Hydrochloride for Injection market size by region, by specification, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Naloxone Hydrochloride for Injection sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Naloxone Hydrochloride for Injection sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by specification, and specification.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Naloxone Hydrochloride for Injection market size forecast by region, by country, by specification, and application.
Chapter 13: Comprehensive company profiles of the leading players, including AuroMedics Pharma, Narcan, Somerset Therapeutics, Flagship Biotech International, Livealth BioPharma, Shanxi PUDE Pharmaceutical, Chengdu Easton Bio Pharmaceuticals, HeBei Aoxing Group Pharmaceutical and Hunan Kangzhe Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Naloxone Hydrochloride for Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Naloxone Hydrochloride for Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Naloxone Hydrochloride for Injection by Country/Region, 2017, 2022 & 2028
2.2 Naloxone Hydrochloride for Injection Segment by Specification
2.2.1 1ml/Unit
2.2.2 2ml/Unit
2.2.3 10ml/Unit
2.3 Naloxone Hydrochloride for Injection Sales by Specification
2.3.1 Global Naloxone Hydrochloride for Injection Sales Market Share by Specification (2017-2022)
2.3.2 Global Naloxone Hydrochloride for Injection Revenue and Market Share by Specification (2017-2022)
2.3.3 Global Naloxone Hydrochloride for Injection Sale Price by Specification (2017-2022)
2.4 Naloxone Hydrochloride for Injection Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Others
2.5 Naloxone Hydrochloride for Injection Sales by Application
2.5.1 Global Naloxone Hydrochloride for Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Naloxone Hydrochloride for Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Naloxone Hydrochloride for Injection Sale Price by Application (2017-2022)
3 Global Naloxone Hydrochloride for Injection by Company
3.1 Global Naloxone Hydrochloride for Injection Breakdown Data by Company
3.1.1 Global Naloxone Hydrochloride for Injection Annual Sales by Company (2020-2022)
3.1.2 Global Naloxone Hydrochloride for Injection Sales Market Share by Company (2020-2022)
3.2 Global Naloxone Hydrochloride for Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Naloxone Hydrochloride for Injection Revenue by Company (2020-2022)
3.2.2 Global Naloxone Hydrochloride for Injection Revenue Market Share by Company (2020-2022)
3.3 Global Naloxone Hydrochloride for Injection Sale Price by Company
3.4 Key Manufacturers Naloxone Hydrochloride for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Naloxone Hydrochloride for Injection Product Location Distribution
3.4.2 Players Naloxone Hydrochloride for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Naloxone Hydrochloride for Injection by Geographic Region
4.1 World Historic Naloxone Hydrochloride for Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Naloxone Hydrochloride for Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Naloxone Hydrochloride for Injection Annual Revenue by Geographic Region
4.2 World Historic Naloxone Hydrochloride for Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Naloxone Hydrochloride for Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Naloxone Hydrochloride for Injection Annual Revenue by Country/Region
4.3 Americas Naloxone Hydrochloride for Injection Sales Growth
4.4 APAC Naloxone Hydrochloride for Injection Sales Growth
4.5 Europe Naloxone Hydrochloride for Injection Sales Growth
4.6 Middle East & Africa Naloxone Hydrochloride for Injection Sales Growth
5 Americas
5.1 Americas Naloxone Hydrochloride for Injection Sales by Country
5.1.1 Americas Naloxone Hydrochloride for Injection Sales by Country (2017-2022)
5.1.2 Americas Naloxone Hydrochloride for Injection Revenue by Country (2017-2022)
5.2 Americas Naloxone Hydrochloride for Injection Sales by Specification
5.3 Americas Naloxone Hydrochloride for Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Naloxone Hydrochloride for Injection Sales by Region
6.1.1 APAC Naloxone Hydrochloride for Injection Sales by Region (2017-2022)
6.1.2 APAC Naloxone Hydrochloride for Injection Revenue by Region (2017-2022)
6.2 APAC Naloxone Hydrochloride for Injection Sales by Specification
6.3 APAC Naloxone Hydrochloride for Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Naloxone Hydrochloride for Injection by Country
7.1.1 Europe Naloxone Hydrochloride for Injection Sales by Country (2017-2022)
7.1.2 Europe Naloxone Hydrochloride for Injection Revenue by Country (2017-2022)
7.2 Europe Naloxone Hydrochloride for Injection Sales by Specification
7.3 Europe Naloxone Hydrochloride for Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Naloxone Hydrochloride for Injection by Country
8.1.1 Middle East & Africa Naloxone Hydrochloride for Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Naloxone Hydrochloride for Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Naloxone Hydrochloride for Injection Sales by Specification
8.3 Middle East & Africa Naloxone Hydrochloride for Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Naloxone Hydrochloride for Injection
10.3 Manufacturing Process Analysis of Naloxone Hydrochloride for Injection
10.4 Industry Chain Structure of Naloxone Hydrochloride for Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Naloxone Hydrochloride for Injection Distributors
11.3 Naloxone Hydrochloride for Injection Customer
12 World Forecast Review for Naloxone Hydrochloride for Injection by Geographic Region
12.1 Global Naloxone Hydrochloride for Injection Market Size Forecast by Region
12.1.1 Global Naloxone Hydrochloride for Injection Forecast by Region (2023-2028)
12.1.2 Global Naloxone Hydrochloride for Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Naloxone Hydrochloride for Injection Forecast by Specification
12.7 Global Naloxone Hydrochloride for Injection Forecast by Application
13 Key Players Analysis
13.1 AuroMedics Pharma
13.1.1 AuroMedics Pharma Company Information
13.1.2 AuroMedics Pharma Naloxone Hydrochloride for Injection Product Offered
13.1.3 AuroMedics Pharma Naloxone Hydrochloride for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AuroMedics Pharma Main Business Overview
13.1.5 AuroMedics Pharma Latest Developments
13.2 Narcan
13.2.1 Narcan Company Information
13.2.2 Narcan Naloxone Hydrochloride for Injection Product Offered
13.2.3 Narcan Naloxone Hydrochloride for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Narcan Main Business Overview
13.2.5 Narcan Latest Developments
13.3 Somerset Therapeutics
13.3.1 Somerset Therapeutics Company Information
13.3.2 Somerset Therapeutics Naloxone Hydrochloride for Injection Product Offered
13.3.3 Somerset Therapeutics Naloxone Hydrochloride for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Somerset Therapeutics Main Business Overview
13.3.5 Somerset Therapeutics Latest Developments
13.4 Flagship Biotech International
13.4.1 Flagship Biotech International Company Information
13.4.2 Flagship Biotech International Naloxone Hydrochloride for Injection Product Offered
13.4.3 Flagship Biotech International Naloxone Hydrochloride for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Flagship Biotech International Main Business Overview
13.4.5 Flagship Biotech International Latest Developments
13.5 Livealth BioPharma
13.5.1 Livealth BioPharma Company Information
13.5.2 Livealth BioPharma Naloxone Hydrochloride for Injection Product Offered
13.5.3 Livealth BioPharma Naloxone Hydrochloride for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Livealth BioPharma Main Business Overview
13.5.5 Livealth BioPharma Latest Developments
13.6 Shanxi PUDE Pharmaceutical
13.6.1 Shanxi PUDE Pharmaceutical Company Information
13.6.2 Shanxi PUDE Pharmaceutical Naloxone Hydrochloride for Injection Product Offered
13.6.3 Shanxi PUDE Pharmaceutical Naloxone Hydrochloride for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Shanxi PUDE Pharmaceutical Main Business Overview
13.6.5 Shanxi PUDE Pharmaceutical Latest Developments
13.7 Chengdu Easton Bio Pharmaceuticals
13.7.1 Chengdu Easton Bio Pharmaceuticals Company Information
13.7.2 Chengdu Easton Bio Pharmaceuticals Naloxone Hydrochloride for Injection Product Offered
13.7.3 Chengdu Easton Bio Pharmaceuticals Naloxone Hydrochloride for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Chengdu Easton Bio Pharmaceuticals Main Business Overview
13.7.5 Chengdu Easton Bio Pharmaceuticals Latest Developments
13.8 HeBei Aoxing Group Pharmaceutical
13.8.1 HeBei Aoxing Group Pharmaceutical Company Information
13.8.2 HeBei Aoxing Group Pharmaceutical Naloxone Hydrochloride for Injection Product Offered
13.8.3 HeBei Aoxing Group Pharmaceutical Naloxone Hydrochloride for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 HeBei Aoxing Group Pharmaceutical Main Business Overview
13.8.5 HeBei Aoxing Group Pharmaceutical Latest Developments
13.9 Hunan Kangzhe Pharmaceutical
13.9.1 Hunan Kangzhe Pharmaceutical Company Information
13.9.2 Hunan Kangzhe Pharmaceutical Naloxone Hydrochloride for Injection Product Offered
13.9.3 Hunan Kangzhe Pharmaceutical Naloxone Hydrochloride for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Hunan Kangzhe Pharmaceutical Main Business Overview
13.9.5 Hunan Kangzhe Pharmaceutical Latest Developments
13.10 Beijing Sihuan Pharmaceutical
13.10.1 Beijing Sihuan Pharmaceutical Company Information
13.10.2 Beijing Sihuan Pharmaceutical Naloxone Hydrochloride for Injection Product Offered
13.10.3 Beijing Sihuan Pharmaceutical Naloxone Hydrochloride for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Beijing Sihuan Pharmaceutical Main Business Overview
13.10.5 Beijing Sihuan Pharmaceutical Latest Developments
13.11 Hainan Bikai Pharmaceutical
13.11.1 Hainan Bikai Pharmaceutical Company Information
13.11.2 Hainan Bikai Pharmaceutical Naloxone Hydrochloride for Injection Product Offered
13.11.3 Hainan Bikai Pharmaceutical Naloxone Hydrochloride for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Hainan Bikai Pharmaceutical Main Business Overview
13.11.5 Hainan Bikai Pharmaceutical Latest Developments
13.12 Chengdu Tiantai Mountain Pharmaceutical
13.12.1 Chengdu Tiantai Mountain Pharmaceutical Company Information
13.12.2 Chengdu Tiantai Mountain Pharmaceutical Naloxone Hydrochloride for Injection Product Offered
13.12.3 Chengdu Tiantai Mountain Pharmaceutical Naloxone Hydrochloride for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Chengdu Tiantai Mountain Pharmaceutical Main Business Overview
13.12.5 Chengdu Tiantai Mountain Pharmaceutical Latest Developments
13.13 Shandong Xinhua Pharmaceutical
13.13.1 Shandong Xinhua Pharmaceutical Company Information
13.13.2 Shandong Xinhua Pharmaceutical Naloxone Hydrochloride for Injection Product Offered
13.13.3 Shandong Xinhua Pharmaceutical Naloxone Hydrochloride for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Shandong Xinhua Pharmaceutical Main Business Overview
13.13.5 Shandong Xinhua Pharmaceutical Latest Developments
13.14 Xi'an Disai Biopharmaceutical
13.14.1 Xi'an Disai Biopharmaceutical Company Information
13.14.2 Xi'an Disai Biopharmaceutical Naloxone Hydrochloride for Injection Product Offered
13.14.3 Xi'an Disai Biopharmaceutical Naloxone Hydrochloride for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Xi'an Disai Biopharmaceutical Main Business Overview
13.14.5 Xi'an Disai Biopharmaceutical Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Naloxone Hydrochloride for Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Naloxone Hydrochloride for Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 1ml/Unit
Table 4. Major Players of 2ml/Unit
Table 5. Major Players of 10ml/Unit
Table 6. Global Naloxone Hydrochloride for Injection Sales by Specification (2017-2022) & (K Units)
Table 7. Global Naloxone Hydrochloride for Injection Sales Market Share by Specification (2017-2022)
Table 8. Global Naloxone Hydrochloride for Injection Revenue by Specification (2017-2022) & ($ million)
Table 9. Global Naloxone Hydrochloride for Injection Revenue Market Share by Specification (2017-2022)
Table 10. Global Naloxone Hydrochloride for Injection Sale Price by Specification (2017-2022) & (US$/Unit)
Table 11. Global Naloxone Hydrochloride for Injection Sales by Application (2017-2022) & (K Units)
Table 12. Global Naloxone Hydrochloride for Injection Sales Market Share by Application (2017-2022)
Table 13. Global Naloxone Hydrochloride for Injection Revenue by Application (2017-2022)
Table 14. Global Naloxone Hydrochloride for Injection Revenue Market Share by Application (2017-2022)
Table 15. Global Naloxone Hydrochloride for Injection Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Naloxone Hydrochloride for Injection Sales by Company (2020-2022) & (K Units)
Table 17. Global Naloxone Hydrochloride for Injection Sales Market Share by Company (2020-2022)
Table 18. Global Naloxone Hydrochloride for Injection Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Naloxone Hydrochloride for Injection Revenue Market Share by Company (2020-2022)
Table 20. Global Naloxone Hydrochloride for Injection Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Naloxone Hydrochloride for Injection Producing Area Distribution and Sales Area
Table 22. Players Naloxone Hydrochloride for Injection Products Offered
Table 23. Naloxone Hydrochloride for Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Naloxone Hydrochloride for Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Naloxone Hydrochloride for Injection Sales Market Share Geographic Region (2017-2022)
Table 28. Global Naloxone Hydrochloride for Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Naloxone Hydrochloride for Injection Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Naloxone Hydrochloride for Injection Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Naloxone Hydrochloride for Injection Sales Market Share by Country/Region (2017-2022)
Table 32. Global Naloxone Hydrochloride for Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Naloxone Hydrochloride for Injection Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Naloxone Hydrochloride for Injection Sales by Country (2017-2022) & (K Units)
Table 35. Americas Naloxone Hydrochloride for Injection Sales Market Share by Country (2017-2022)
Table 36. Americas Naloxone Hydrochloride for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Naloxone Hydrochloride for Injection Revenue Market Share by Country (2017-2022)
Table 38. Americas Naloxone Hydrochloride for Injection Sales by Type (2017-2022) & (K Units)
Table 39. Americas Naloxone Hydrochloride for Injection Sales Market Share by Specification (2017-2022)
Table 40. Americas Naloxone Hydrochloride for Injection Sales by Application (2017-2022) & (K Units)
Table 41. Americas Naloxone Hydrochloride for Injection Sales Market Share by Application (2017-2022)
Table 42. APAC Naloxone Hydrochloride for Injection Sales by Region (2017-2022) & (K Units)
Table 43. APAC Naloxone Hydrochloride for Injection Sales Market Share by Region (2017-2022)
Table 44. APAC Naloxone Hydrochloride for Injection Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Naloxone Hydrochloride for Injection Revenue Market Share by Region (2017-2022)
Table 46. APAC Naloxone Hydrochloride for Injection Sales by Specification (2017-2022) & (K Units)
Table 47. APAC Naloxone Hydrochloride for Injection Sales Market Share by Specification (2017-2022)
Table 48. APAC Naloxone Hydrochloride for Injection Sales by Application (2017-2022) & (K Units)
Table 49. APAC Naloxone Hydrochloride for Injection Sales Market Share by Application (2017-2022)
Table 50. Europe Naloxone Hydrochloride for Injection Sales by Country (2017-2022) & (K Units)
Table 51. Europe Naloxone Hydrochloride for Injection Sales Market Share by Country (2017-2022)
Table 52. Europe Naloxone Hydrochloride for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Naloxone Hydrochloride for Injection Revenue Market Share by Country (2017-2022)
Table 54. Europe Naloxone Hydrochloride for Injection Sales by Type (2017-2022) & (K Units)
Table 55. Europe Naloxone Hydrochloride for Injection Sales Market Share by Specification (2017-2022)
Table 56. Europe Naloxone Hydrochloride for Injection Sales by Application (2017-2022) & (K Units)
Table 57. Europe Naloxone Hydrochloride for Injection Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Naloxone Hydrochloride for Injection Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Naloxone Hydrochloride for Injection Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Naloxone Hydrochloride for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Naloxone Hydrochloride for Injection Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Naloxone Hydrochloride for Injection Sales by Specification (2017-2022) & (K Units)
Table 63. Middle East & Africa Naloxone Hydrochloride for Injection Sales Market Share by Specification (2017-2022)
Table 64. Middle East & Africa Naloxone Hydrochloride for Injection Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Naloxone Hydrochloride for Injection Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Naloxone Hydrochloride for Injection
Table 67. Key Market Challenges & Risks of Naloxone Hydrochloride for Injection
Table 68. Key Industry Trends of Naloxone Hydrochloride for Injection
Table 69. Naloxone Hydrochloride for Injection Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Naloxone Hydrochloride for Injection Distributors List
Table 72. Naloxone Hydrochloride for Injection Customer List
Table 73. Global Naloxone Hydrochloride for Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Naloxone Hydrochloride for Injection Sales Market Forecast by Region
Table 75. Global Naloxone Hydrochloride for Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Naloxone Hydrochloride for Injection Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Naloxone Hydrochloride for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Naloxone Hydrochloride for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Naloxone Hydrochloride for Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Naloxone Hydrochloride for Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Naloxone Hydrochloride for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Naloxone Hydrochloride for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Naloxone Hydrochloride for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Naloxone Hydrochloride for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Naloxone Hydrochloride for Injection Sales Forecast by Specification (2023-2028) & (K Units)
Table 86. Global Naloxone Hydrochloride for Injection Sales Market Share Forecast by Specification (2023-2028)
Table 87. Global Naloxone Hydrochloride for Injection Revenue Forecast by Specification (2023-2028) & ($ Millions)
Table 88. Global Naloxone Hydrochloride for Injection Revenue Market Share Forecast by Specification (2023-2028)
Table 89. Global Naloxone Hydrochloride for Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Naloxone Hydrochloride for Injection Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Naloxone Hydrochloride for Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Naloxone Hydrochloride for Injection Revenue Market Share Forecast by Application (2023-2028)
Table 93. AuroMedics Pharma Basic Information, Naloxone Hydrochloride for Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. AuroMedics Pharma Naloxone Hydrochloride for Injection Product Offered
Table 95. AuroMedics Pharma Naloxone Hydrochloride for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. AuroMedics Pharma Main Business
Table 97. AuroMedics Pharma Latest Developments
Table 98. Narcan Basic Information, Naloxone Hydrochloride for Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Narcan Naloxone Hydrochloride for Injection Product Offered
Table 100. Narcan Naloxone Hydrochloride for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Narcan Main Business
Table 102. Narcan Latest Developments
Table 103. Somerset Therapeutics Basic Information, Naloxone Hydrochloride for Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Somerset Therapeutics Naloxone Hydrochloride for Injection Product Offered
Table 105. Somerset Therapeutics Naloxone Hydrochloride for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Somerset Therapeutics Main Business
Table 107. Somerset Therapeutics Latest Developments
Table 108. Flagship Biotech International Basic Information, Naloxone Hydrochloride for Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Flagship Biotech International Naloxone Hydrochloride for Injection Product Offered
Table 110. Flagship Biotech International Naloxone Hydrochloride for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Flagship Biotech International Main Business
Table 112. Flagship Biotech International Latest Developments
Table 113. Livealth BioPharma Basic Information, Naloxone Hydrochloride for Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Livealth BioPharma Naloxone Hydrochloride for Injection Product Offered
Table 115. Livealth BioPharma Naloxone Hydrochloride for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Livealth BioPharma Main Business
Table 117. Livealth BioPharma Latest Developments
Table 118. Shanxi PUDE Pharmaceutical Basic Information, Naloxone Hydrochloride for Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Shanxi PUDE Pharmaceutical Naloxone Hydrochloride for Injection Product Offered
Table 120. Shanxi PUDE Pharmaceutical Naloxone Hydrochloride for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Shanxi PUDE Pharmaceutical Main Business
Table 122. Shanxi PUDE Pharmaceutical Latest Developments
Table 123. Chengdu Easton Bio Pharmaceuticals Basic Information, Naloxone Hydrochloride for Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Chengdu Easton Bio Pharmaceuticals Naloxone Hydrochloride for Injection Product Offered
Table 125. Chengdu Easton Bio Pharmaceuticals Naloxone Hydrochloride for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Chengdu Easton Bio Pharmaceuticals Main Business
Table 127. Chengdu Easton Bio Pharmaceuticals Latest Developments
Table 128. HeBei Aoxing Group Pharmaceutical Basic Information, Naloxone Hydrochloride for Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. HeBei Aoxing Group Pharmaceutical Naloxone Hydrochloride for Injection Product Offered
Table 130. HeBei Aoxing Group Pharmaceutical Naloxone Hydrochloride for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. HeBei Aoxing Group Pharmaceutical Main Business
Table 132. HeBei Aoxing Group Pharmaceutical Latest Developments
Table 133. Hunan Kangzhe Pharmaceutical Basic Information, Naloxone Hydrochloride for Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Hunan Kangzhe Pharmaceutical Naloxone Hydrochloride for Injection Product Offered
Table 135. Hunan Kangzhe Pharmaceutical Naloxone Hydrochloride for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Hunan Kangzhe Pharmaceutical Main Business
Table 137. Hunan Kangzhe Pharmaceutical Latest Developments
Table 138. Beijing Sihuan Pharmaceutical Basic Information, Naloxone Hydrochloride for Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Beijing Sihuan Pharmaceutical Naloxone Hydrochloride for Injection Product Offered
Table 140. Beijing Sihuan Pharmaceutical Naloxone Hydrochloride for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Beijing Sihuan Pharmaceutical Main Business
Table 142. Beijing Sihuan Pharmaceutical Latest Developments
Table 143. Hainan Bikai Pharmaceutical Basic Information, Naloxone Hydrochloride for Injection Manufacturing Base, Sales Area and Its Competitors
Table 144. Hainan Bikai Pharmaceutical Naloxone Hydrochloride for Injection Product Offered
Table 145. Hainan Bikai Pharmaceutical Naloxone Hydrochloride for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Hainan Bikai Pharmaceutical Main Business
Table 147. Hainan Bikai Pharmaceutical Latest Developments
Table 148. Chengdu Tiantai Mountain Pharmaceutical Basic Information, Naloxone Hydrochloride for Injection Manufacturing Base, Sales Area and Its Competitors
Table 149. Chengdu Tiantai Mountain Pharmaceutical Naloxone Hydrochloride for Injection Product Offered
Table 150. Chengdu Tiantai Mountain Pharmaceutical Naloxone Hydrochloride for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Chengdu Tiantai Mountain Pharmaceutical Main Business
Table 152. Chengdu Tiantai Mountain Pharmaceutical Latest Developments
Table 153. Shandong Xinhua Pharmaceutical Basic Information, Naloxone Hydrochloride for Injection Manufacturing Base, Sales Area and Its Competitors
Table 154. Shandong Xinhua Pharmaceutical Naloxone Hydrochloride for Injection Product Offered
Table 155. Shandong Xinhua Pharmaceutical Naloxone Hydrochloride for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. Shandong Xinhua Pharmaceutical Main Business
Table 157. Shandong Xinhua Pharmaceutical Latest Developments
Table 158. Xi'an Disai Biopharmaceutical Basic Information, Naloxone Hydrochloride for Injection Manufacturing Base, Sales Area and Its Competitors
Table 159. Xi'an Disai Biopharmaceutical Naloxone Hydrochloride for Injection Product Offered
Table 160. Xi'an Disai Biopharmaceutical Naloxone Hydrochloride for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. Xi'an Disai Biopharmaceutical Main Business
Table 162. Xi'an Disai Biopharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Naloxone Hydrochloride for Injection
Figure 2. Naloxone Hydrochloride for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Naloxone Hydrochloride for Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Naloxone Hydrochloride for Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Naloxone Hydrochloride for Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 1ml/Unit
Figure 10. Product Picture of 2ml/Unit
Figure 11. Product Picture of 10ml/Unit
Figure 12. Global Naloxone Hydrochloride for Injection Sales Market Share by Specification in 2021
Figure 13. Global Naloxone Hydrochloride for Injection Revenue Market Share by Specification (2017-2022)
Figure 14. Naloxone Hydrochloride for Injection Consumed in Hospital Pharmacy
Figure 15. Global Naloxone Hydrochloride for Injection Market: Hospital Pharmacy (2017-2022) & (K Units)
Figure 16. Naloxone Hydrochloride for Injection Consumed in Retail Pharmacy
Figure 17. Global Naloxone Hydrochloride for Injection Market: Retail Pharmacy (2017-2022) & (K Units)
Figure 18. Naloxone Hydrochloride for Injection Consumed in Others
Figure 19. Global Naloxone Hydrochloride for Injection Market: Others (2017-2022) & (K Units)
Figure 20. Global Naloxone Hydrochloride for Injection Sales Market Share by Application (2017-2022)
Figure 21. Global Naloxone Hydrochloride for Injection Revenue Market Share by Application in 2021
Figure 22. Naloxone Hydrochloride for Injection Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Naloxone Hydrochloride for Injection Revenue Market Share by Company in 2021
Figure 24. Global Naloxone Hydrochloride for Injection Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Naloxone Hydrochloride for Injection Revenue Market Share by Geographic Region in 2021
Figure 26. Global Naloxone Hydrochloride for Injection Sales Market Share by Region (2017-2022)
Figure 27. Global Naloxone Hydrochloride for Injection Revenue Market Share by Country/Region in 2021
Figure 28. Americas Naloxone Hydrochloride for Injection Sales 2017-2022 (K Units)
Figure 29. Americas Naloxone Hydrochloride for Injection Revenue 2017-2022 ($ Millions)
Figure 30. APAC Naloxone Hydrochloride for Injection Sales 2017-2022 (K Units)
Figure 31. APAC Naloxone Hydrochloride for Injection Revenue 2017-2022 ($ Millions)
Figure 32. Europe Naloxone Hydrochloride for Injection Sales 2017-2022 (K Units)
Figure 33. Europe Naloxone Hydrochloride for Injection Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Naloxone Hydrochloride for Injection Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Naloxone Hydrochloride for Injection Revenue 2017-2022 ($ Millions)
Figure 36. Americas Naloxone Hydrochloride for Injection Sales Market Share by Country in 2021
Figure 37. Americas Naloxone Hydrochloride for Injection Revenue Market Share by Country in 2021
Figure 38. United States Naloxone Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Naloxone Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Naloxone Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Naloxone Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Naloxone Hydrochloride for Injection Sales Market Share by Region in 2021
Figure 43. APAC Naloxone Hydrochloride for Injection Revenue Market Share by Regions in 2021
Figure 44. China Naloxone Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Naloxone Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Naloxone Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Naloxone Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Naloxone Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Naloxone Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Naloxone Hydrochloride for Injection Sales Market Share by Country in 2021
Figure 51. Europe Naloxone Hydrochloride for Injection Revenue Market Share by Country in 2021
Figure 52. Germany Naloxone Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Naloxone Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Naloxone Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Naloxone Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Naloxone Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Naloxone Hydrochloride for Injection Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Naloxone Hydrochloride for Injection Revenue Market Share by Country in 2021
Figure 59. Egypt Naloxone Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Naloxone Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Naloxone Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Naloxone Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Naloxone Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Naloxone Hydrochloride for Injection in 2021
Figure 65. Manufacturing Process Analysis of Naloxone Hydrochloride for Injection
Figure 66. Industry Chain Structure of Naloxone Hydrochloride for Injection
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets